Volume 197 - Issue 9

Eliminating childhood lead toxicity in Australia: a call to lower the intervention level

Authors:  Mark P Taylor, Chris Winder and Bruce P Lanphear

Med J Aust 2012; 197 (9): 493. || doi: 10.5694/mja12.11159
Published online: 5 November 2012
To the Editor: On 5 June 2012, the forum “Eliminating childhood lead toxicity in Australia - a little is still too much” was held at Macquarie University to examine new evidence on the toxicity of lead and its implications for Australian children and communities. Presently, the National Health and Medical Research Council (NHMRC) recommends an increasingly obsolete intervention level that was established in 1993: blood lead levels ...

To the Editor: On 5 June 2012, the forum “Eliminating childhood lead toxicity in Australia — a little is still too much” was held at Macquarie University to examine new evidence on the toxicity of lead and its implications for Australian children and communities.

Presently, the National Health and Medical Research Council (NHMRC) recommends an increasingly obsolete intervention level that was established in 1993: blood lead levels of below 10 μg/dL. However, new and overwhelming evidence indicates that even levels below 5 μg/dL are associated with a range of adverse health outcomes, including decreased intelligence and academic achievement, sociobehavioural problems such as attention deficit hyperactivity disorder, learning difficulties, oppositional and conduct disorders, and delinquency. Importantly, the greatest relative effects on IQ occur at the lower blood lead levels (Box).1

In Germany, the reference value for blood lead levels in 3–14-year-olds was lowered in 2009 to 3.5 μg/dL.2 In 2012, the US Centers for Disease Control and Prevention eliminated the “level of concern” set previously at 10 μg/dL and established 5 μg/dL as the intervention level for individual children.3 Also in 2012, the US National Toxicology Program concluded that levels below 5 μg/dL are associated with detrimental health outcomes in children and adults.4

The potential risk of low lead exposure in Australian children can be estimated using US exposure rates and Australian population data. About 7.4% of US children aged 1–5 years have a blood lead level above 5 μg/dL. Applying this rate to Australian children aged 0–4 years suggests that about 100 000 may have blood lead levels associated with adverse health outcomes.

At the Macquarie University forum on lead toxicity, consensus was reached that the NHMRC goal should be lowered.5 To eliminate childhood lead toxicity in Australia, we need to improve ways of identifying sources of lead exposure, assessing the impacts of lead exposure, and eliminating or controlling lead risks. Relevant legislation and standards relating to health and environmental levels of lead should be revised to achieve blood lead levels below 1 μg/dL. Community involvement in implementing the necessary changes and cost–benefit analyses of interventions were also called for at the forum.


Authors


Competing interests


Acknowledgements


References


More like this

Child health Research 1 October 2026 Open Access

Barriers and Facilitators to Timely Detection and Optimal Management of Chronic Wet Cough in Aboriginal Children Across Australia From the Perspectives of Carers of Aboriginal Children: A Qualitative Study

Gloria T. Y. Lau, Pam Laird, Robyn Aitken, Melanie Barwick, Liam Bedford, Emily R. Bowden, Jamie Everingham, Angela Fuery, Reece Griffin, Neha Jain, Mina Kinghorn, Renae Knapp, Gabrielle B. McCallum, Peter Morris, Richard Norman, Peter C. Richmond, Aarti Saiganesh, Slade Sibosado, Cameron Taylor, Maree Toombs, Roz Walker, Joan Wilson, Anne B. Chang, André Schultz

Child health Research 30 September 2026 Open Access

Barriers and Facilitators to Timely Detection and Optimal Management of Chronic Wet Cough in Aboriginal Children Across Australia From the Perspective of Health Care Providers: A Qualitative Study

Gloria T. Y. Lau, Pamela Laird, Robyn Aitken, Melanie Barwick, Liam Bedford, Emily R. Bowden, Corey Dalton, Jamie Everingham, Angela Fuery, Reece Griffin, Neha Jain, Mina Kinghorn, Renae Knapp, Gabrielle B. McCallum, Peter Morris, Richard Norman, Peter C. Richmond, Aarti Saiganesh, Slade Sibosado, Maree Toombs, Roz Walker, Joan Wilson, Anne B. Chang, André Schultz

Child health Research 13 August 2026 Open Access

Watchful Waiting Compared With Immediate Antibiotics for Urban Aboriginal and Torres Strait Islander Children With Uncomplicated Acute Otitis Media (WATCH): A Non-Inferiority Randomised Controlled Trial

Jennifer S. Reath, Hasantha Gunasekera, Sanja Lujic, Amanda J. Leach, Letitia Campbell, Robyn Walsh, Tim Usherwood, Geoffrey K. Spurling, Claudette A. Tyson, Deborah A. Askew, Kelvin Kong, Chelsea J. Watego, Peter Morris, Wendy Hu, Penelope A. Abbott